Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
FEBS Letters
|
November 1, 2020
The role of brain innate immune response in lysosomal storage disorders: fundamental process or evolutionary side effect?
Einat B Vitner
Handbook of Experimental Pharmacology
|
April 9, 2013
Neuronal forms of Gaucher disease
Einat B Vitner, Anthony H Futerman
Biological Chemistry
|
February 27, 2015
Innate immune responses in the brain of sphingolipid lysosomal storage diseases
Einat B Vitner, Anthony H Futerman, Nick Platt
The Journal of Biological Chemistry
|
May 1, 2010
Common and uncommon pathogenic cascades in lysosomal storage diseases
Einat B Vitner, Frances M Platt, Anthony H Futerman
Disease Models & Mechanisms
|
September 29, 2011
Animal models for Gaucher disease research
Tamar Farfel-Becker, Einat B Vitner, Anthony H Futerman
Expert Opinion on Therapeutic Targets
|
November 23, 2014
Emerging therapeutic targets for Gaucher disease
Einat B Vitner, Ayelet Vardi, Timothy M Cox, et al.
Life Science Alliance
|
November 12, 2021
Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
Einat B Vitner, Roy Avraham, Boaz Politi, et al.
Brain : a Journal of Neurology
|
May 9, 2012
Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease
Einat B Vitner, Tamar Farfel-Becker, Raya Eilam, et al.
Human Molecular Genetics
|
January 22, 2011
Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease
Tamar Farfel-Becker, Einat B Vitner, Sarah N R Pressey, et al.
Journal of Neuroinflammation
|
May 14, 2016
Induction of the type I interferon response in neurological forms of Gaucher disease
Einat B Vitner, Tamar Farfel-Becker, Natalia Santos Ferreira, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
FEBS Letters
|
November 1, 2020
The role of brain innate immune response in lysosomal storage disorders: fundamental process or evolutionary side effect?
Einat B Vitner
Handbook of Experimental Pharmacology
|
April 9, 2013
Neuronal forms of Gaucher disease
Einat B Vitner, Anthony H Futerman
Biological Chemistry
|
February 27, 2015
Innate immune responses in the brain of sphingolipid lysosomal storage diseases
Einat B Vitner, Anthony H Futerman, Nick Platt
The Journal of Biological Chemistry
|
May 1, 2010
Common and uncommon pathogenic cascades in lysosomal storage diseases
Einat B Vitner, Frances M Platt, Anthony H Futerman
Disease Models & Mechanisms
|
September 29, 2011
Animal models for Gaucher disease research
Tamar Farfel-Becker, Einat B Vitner, Anthony H Futerman
Expert Opinion on Therapeutic Targets
|
November 23, 2014
Emerging therapeutic targets for Gaucher disease
Einat B Vitner, Ayelet Vardi, Timothy M Cox, et al.
Life Science Alliance
|
November 12, 2021
Elevation in sphingolipid upon SARS-CoV-2 infection: possible implications for COVID-19 pathology
Einat B Vitner, Roy Avraham, Boaz Politi, et al.
Brain : a Journal of Neurology
|
May 9, 2012
Contribution of brain inflammation to neuronal cell death in neuronopathic forms of Gaucher's disease
Einat B Vitner, Tamar Farfel-Becker, Raya Eilam, et al.
Human Molecular Genetics
|
January 22, 2011
Spatial and temporal correlation between neuron loss and neuroinflammation in a mouse model of neuronopathic Gaucher disease
Tamar Farfel-Becker, Einat B Vitner, Sarah N R Pressey, et al.
Journal of Neuroinflammation
|
May 14, 2016
Induction of the type I interferon response in neurological forms of Gaucher disease
Einat B Vitner, Tamar Farfel-Becker, Natalia Santos Ferreira, et al.
Page
of 3